Serious cardiac arrhythmias after stroke: incidence, time course, and predictors--a systematic, prospective analysis

Stroke. 2012 Nov;43(11):2892-7. doi: 10.1161/STROKEAHA.112.664318. Epub 2012 Sep 6.

Abstract

Background and purpose: Patients with acute cerebrovascular events are susceptible to serious cardiac arrhythmias, but data on the time course and the determinants of their onset are scarce.

Methods: The prospective Stroke-Arrhythmia-Monitoring-Database (SAMBA) assessed cardiac arrhythmias with need for urgent evaluation and treatment in 501 acute neurovascular patients during the first 72 hours after admission to a monitored stroke unit. Arrhythmias were systematically detected by structured processing of telemetric data. Time of arrhythmia onset and predisposing factors were investigated.

Results: Significant cardiac arrhythmias occurred in 25.1% of all patients. Incidence was highest during the first 24 hours after admission. Serious arrhythmic tachycardia (ventricular or supraventricular>130 beats/min) was more frequent than bradycardic arrhythmia (sinus-node dysfunction, bradyarrhythmia, or atrioventricular block °II and °III). Arrhythmias were independently associated with higher age and severer neurological deficits as measured by the National Institutes of Health Stroke Scale on admission.

Conclusions: The risk for significant cardiac arrhythmia after an acute cerebrovascular event is highest during the first 24 hours of care and declines with time during the first 3 days. Along with established vascular risk factors, the National Institutes of Health Stroke Scale may be considered for a stratified allocation of monitoring capabilities.

Clinical trial registration: URL: www.clinicaltrials.gov. Unique identifier: NCT01177748.

Publication types

  • Clinical Trial

MeSH terms

  • Age Distribution
  • Age Factors
  • Aged
  • Aged, 80 and over
  • Arrhythmias, Cardiac / epidemiology*
  • Arrhythmias, Cardiac / etiology*
  • Female
  • Humans
  • Incidence
  • Male
  • Middle Aged
  • Prospective Studies
  • Stroke / complications*
  • Time Factors

Associated data

  • ClinicalTrials.gov/NCT01177748